LONDON — Building up its base of medicines for lung diseases, GSK said Wednesday it was buying the privately held firm 35Pharma for $950 million in cash. The centerpiece of the deal is an experimental ...

GSK’s London-listed shares fell even more swiftly than their ADRs to news that advisers to the Centers for Disease Control and Prevention shifted their recommendations for who should be vaccinated ...

On Monday, Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist investor Starboard Value has invested approximately $1 billion ...

GSK has agreed to pay $950 million in cash for Canadian biotech 35Pharma, it said on Wednesday, marking the second major deal new CEO ​Luke Miels has struck to accelerate development of ‌new medicines ...

The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: GSK offices in London LONDON (Reuters) -British drugmaker GSK said on Wednesday it is in talks with the Trump ...

GSK shares dropped by the most in nearly two years after a ruling by the Delaware State Court that will allow jury trials in cases brought by cancer sufferers who say the heartburn drug Zantac caused ...

GSK activity on the NYSE Composite highlights elevated options trading, institutional participation, and corporate updates ...

GSK has brought its message about the risks of antimicrobial resistance (AMR) to commuters in London. The drugmaker worked with its partner the Fleming Initiative to tell people traveling through ...